Hemodynamic effects of phosphodiesterase 5 and angiotensin-converting enzyme inhibition alone or in combination in conscious SHR

Journal of Pharmacology and Experimental Therapeutics

Volumn 312, Issue 1, 2005, Pages 265-271

  Gardiner, S M ^a   March, J E ^a   Kemp, P A ^a   Ballard, S A ^b   Hawkeswood, E ^b   Hughes, B ^b   Bennett, T ^a  

^a UNIVERSITY OF NOTTINGHAM   (United Kingdom)

^b PFIZER INC   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

DIPEPTIDYL CARBOXYPEPTIDASE; ENALAPRIL; PHOSPHODIESTERASE V; PHOSPHODIESTERASE V INHIBITOR; UK 357,903 (1 ETHYL 4 (3 (3 ETHYL 6,7 DIHYDRO 7 OXO 2 (2 PYRIDYLMETHYL) 2H PYRAZOLO (4,3 D)PYRIMIDIN 5YL) 2 (2 METHOXYETHOXY)5 PYRIDYLSULPHONYL)PIPERAZINE); UNCLASSIFIED DRUG;

ANIMAL CELL; ARTICLE; BLOOD LEVEL; BLOOD PRESSURE; CONDUCTANCE; DATA ANALYSIS; DOPPLER FLOWMETRY; HEMODYNAMICS; HYPOTENSION; KIDNEY; MALE; MEAN ARTERIAL PRESSURE; MESENTERY; MESENTERY BLOOD FLOW; NONHUMAN; PRIORITY JOURNAL; RAT; RENIN ANGIOTENSIN ALDOSTERONE SYSTEM; SPONTANEOUSLY HYPERTENSIVE RAT; VASODILATATION;

3',5'-CYCLIC-GMP PHOSPHODIESTERASE; ANGIOTENSIN-CONVERTING ENZYME INHIBITORS; ANIMALS; BLOOD PRESSURE; CARDIOVASCULAR SYSTEM; CYCLIC GMP; FEMALE; HEART RATE; KIDNEY; MALE; MESENTERIC ARTERIES; PHOSPHODIESTERASE INHIBITORS; RATS; RATS, INBRED SHR; RENIN;

EID: 11844253232     PISSN: 00223565     EISSN: None     Source Type: Journal    
DOI: 10.1124/jpet.104.071993     Document Type: Article

References (15)

1. Ballard SA, Gingell CJ, Tang K, Turner LA, Price ME, and Naylor AM (1998) Effects of sildenafil on the relaxation of human corpus cavernosum tissue in vitro and on the activities of cyclic nucleotide phosphodiesterase isozymes. J Urol 159:2164-2171.
2. Blair R, Fishman B, Amit Z, and Weeks JR (1980) A simple double channel swivel for infusion of fluids into unrestrained animals. Pharmacol Biochem Behav 12:463-466.
3. Chiu YJ and Reid IA (2002) Effect of sildenafil on renin secretion in human subjects. Exp Biol Med (Maywood) 227:620-625.
4. Gainer JV, Morrow JD, Loveland A, King DJ, and Brown NJ (1998) Effect of bradykinin-receptor blockade on the response to angiotensin-converting-enzyme inhibitor in normotensive and hypertensive subjects. N Eng J Med 339:1285-1292.
5. Gardiner SM, March JE, Kemp PA, Ballard SA, Hawkeswood E, Hughes B, and Bennett T (2004) Haemodynamic effects of the selective phosphodiesterase 5 inhibitor, UK-357,903 in conscious, SHR. Br J Pharmacol 141:114-122.
6. Gohlke P, Linz W, Scholkens BA, Kuwere I, Bartenbach S, Schnell A, and Unger T (1994) Angiotensin-converting enzyme inhibition improves cardiac function. Role of bradykinin. Hypertension 23:411-418.
7. Kanagawa R, Wada T, Sanada T, Ojima M, and Inada Y (1997) Regional hemodynamic effects of candesartan cilexitil (TCV-116), an angiotensin II AT(1)-receptor antagonist, in conscious spontaneously hypertensive rats. Jpn J Pharmacol 73:185-190.
8. Kohno M, Yokokawa K, Minami M, Yasunari K, Maeda K, Kano H, Hanehira T, and Yoshikawa J (1999) Plasma levels of NO and related vasoactive factors following long-term treatment with angiotensin-converting enzyme inhibitor in patients with essential hypertension. Metabolism 48:1256-1259.
9. Lappe RW, Todt JA, and Wendt RL (1985) Graded vasodilatation with converting enzyme inhibitors in conscious spontaneously hypertensive rats. J Pharmacol Exp Ther 235:651-656.
10. Phillips BG, Kato M, Pesek CA, Winnicki M, Narkiewicz K, Davison D, and Somers VR (2000) Sympathetic activation by sildenafil. Circulation 102:3068-3073.
11. Saijonmaa O and Fyhrquist F (1998) Upregulation of angiotensin converting enzyme by atrial natriuretic peptide and cyclic GMP in human endothelial cells. Cardiovasc Res 40:206-210.
12. Smits JF and Struyker-Boudier HA (1984) Systemic and regional hemodynamic effects following acute inhibition of angiotensin-1 converting enzyme in the conscious spontaneously hypertensive rat. Prog Pharmacol 5:40-49.
13. Squire IB, O'Kane KP, Anderson N, and Reid JL (2000) Bradykinin B(2) receptor antagonism attenuates blood pressure response to acute angiotensin-converting enzyme inhibition in normal men. Hypertension 36:132-136.
14. Weisser K and Schloos J (1991) The role of enzyme and substrate concentration in the evaluation of serum angiotensin converting enzyme (ACE) inhibition by enalaprilat in vitro. Biochem Pharmacol 42:1729-1737.
15. Weisser K and Schloos J (1993) Measurements of serum ACE activity in vitro after administration of enalapril in man cannot reflect inhibition of the enzyme in vivo. Methods Find Exp Clin Pharmacol 15:413-418.